Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

On a morning in November 2023 Eamon Keenan, a psychiatrist who runs addiction services at Ireland’s state-funded health-care provider, received a worrying phone call. “People in homeless accommodation ...

CHICAGO — A big breakthrough in cancer research and it’s all due to a tiny structure. The science was developed in Chicago. They took an old drug and made it better. The restructured drug appears to ...

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

A University of Maryland, Baltimore County (UMBC) study, published in Nature Communications, uncovers how enteroviruses—including those causing polio, myocarditis, encephalitis, and the common ...

Antibiotic resistance is one of the most urgent problems facing humanity, but it’s been decades since we last developed a new class of these drugs. That could all be about to change thanks to the ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses and patients. By Jan Hoffman President Trump on Thursday ordered cannabis to ...

Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of the Atlantic. Nitazenes were first synthesized in the 1950s by CIBA ...